|
Model Number B1005 |
Device Problem
Inflation Problem (1310)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 12/31/2015 |
Event Type
malfunction
|
Manufacturer Narrative
|
Ra has received the incident device and has been assigned to engineering for evaluation.A follow-up report will be sent upon completion of investigation.In accordance to 21 cfr 803.56, if we obtain additional information, which was not known or was not available when the initial report was submitted, then the supplemental report will be submitted to the fda.
|
|
Event Description
|
Acucsie endopyelotomy - "dr.(b)(6) performed the procedure.The balloon did not stay inflated following activation of the cutting wire.Wire was activated for 5 seconds at 75w pure cut.Device was observed to hold inflation for cutting step of procedure, but when fluoroscopy was performed minutes after, no contrast solution remained in the balloon.Upon removal of device, damage to the balloon was observed.After removal of the device, a 2cc syringe of sterile water was injected into the balloon inflation port and leakage was confirmed.This b1005 was part of the bk002 kit lot 1248705." patient status - "na.".
|
|
Manufacturer Narrative
|
Investigation summary: the event unit was returned for evaluation.Upon testing, engineering identified a ruptured balloon and silicone sheath.The leakage may be attributed to high thermal activity of the cutting wire, which resulted in the balloon rupturing and causing it to be unable to remain inflated.A review of the manufacturing records indicated this lot passed all manufacturing and quality inspections.The hazard analysis for this device was reviewed and it was determined that the risk levels remain unchanged and acceptable.Applied medical will continue to monitor its vigilance system for trends and take appropriate actions as necessary.In accordance to 21 cfr 803.56, if we obtain additional information, which was not known or was not available when this report was submitted, then a supplemental report will be submitted to the fda.
|
|
Search Alerts/Recalls
|
|
|